These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 30503072)
1. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates. De Bruycker A; De Bleser E; Decaestecker K; Fonteyne V; Lumen N; De Visschere P; De Man K; Delrue L; Lambert B; Ost P Eur Urol; 2019 May; 75(5):826-833. PubMed ID: 30503072 [TBL] [Abstract][Full Text] [Related]
2. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy. De Bleser E; Jereczek-Fossa BA; Pasquier D; Zilli T; Van As N; Siva S; Fodor A; Dirix P; Gomez-Iturriaga A; Trippa F; Detti B; Ingrosso G; Triggiani L; Bruni A; Alongi F; Reynders D; De Meerleer G; Surgo A; Loukili K; Miralbell R; Silva P; Chander S; Di Muzio NG; Maranzano E; Francolini G; Lancia A; Tree A; Deantoni CL; Ponti E; Marvaso G; Goetghebeur E; Ost P Eur Urol; 2019 Dec; 76(6):732-739. PubMed ID: 31331782 [TBL] [Abstract][Full Text] [Related]
3. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy. Oderda M; Joniau S; Palazzetti A; Falcone M; Melloni G; Van Den Bossche H; Deconinck S; Zattoni F; Karnes RJ; Gontero P Eur Urol Focus; 2018 Mar; 4(2):288-293. PubMed ID: 30205893 [TBL] [Abstract][Full Text] [Related]
4. An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer Patients. Trapp C; Oliinyk D; Rogowski P; von Bestenbostel R; Ganswindt U; Li M; Eze C; Bartenstein P; Beyer L; Ilhan H; Sheikh G; Unterrainer L; Stief C; Westhofen T; Kunz WG; Unterrainer M; Belka C; Schmidt-Hegemann NS J Nucl Med; 2023 Jun; 64(6):918-923. PubMed ID: 36732055 [TBL] [Abstract][Full Text] [Related]
5. Oligorecurrent Nodal Prostate Cancer: Long-term Results of an Elective Nodal Irradiation Approach. Tran S; Jorcano S; Falco T; Lamanna G; Miralbell R; Zilli T Am J Clin Oncol; 2018 Oct; 41(10):960-962. PubMed ID: 29315174 [TBL] [Abstract][Full Text] [Related]
6. Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study. Steuber T; Jilg C; Tennstedt P; De Bruycker A; Tilki D; Decaestecker K; Zilli T; Jereczek-Fossa BA; Wetterauer U; Grosu AL; Schultze-Seemann W; Heinzer H; Graefen M; Morlacco A; Karnes RJ; Ost P Eur Urol Focus; 2019 Nov; 5(6):1007-1013. PubMed ID: 29530632 [TBL] [Abstract][Full Text] [Related]
7. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. Rigatti P; Suardi N; Briganti A; Da Pozzo LF; Tutolo M; Villa L; Gallina A; Capitanio U; Abdollah F; Scattoni V; Colombo R; Freschi M; Picchio M; Messa C; Guazzoni G; Montorsi F Eur Urol; 2011 Nov; 60(5):935-43. PubMed ID: 21840116 [TBL] [Abstract][Full Text] [Related]